Intensity Therapeutics, Inc. filed its S-1/A on May 18, 2023 for the period ending Dec 31, 2022. In this report its auditor, EisnerAmper LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | -0.39% | +3.27% | -41.07% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.07% | 6.92Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+45.66% | 4.07TCr | |
-10.72% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- INTS Stock
- News Intensity Therapeutics, Inc.
- Intensity Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt